Kelly Shanahan, Director at METAvivor Research And Support, shared an update from METAvivor, on X, adding:
“Brain metastasis occur in almost half of cases of metastatic HER2+ and TNBC, but also in ER+. We need effective brain penetrant treatments for all subtypes of MBC. METAvivor is funding some pretty cool research in the brain and leptomeningeal metastasis space. Please donate!”
Quoting METAvivor:
“Day 22 Brain Metastases in Breast Cancer
One major challenge: the blood-brain barrier. Treatments currently work only for certain subtypes. We need more research to develop effective treatments for ALL patients with brain metastases.”
You can also read:
FLASH SRS With Proton Bragg Peak Tracking Achieves IMPT Equivalent Brain Metastasis Dosimetry
